https://www.fool.com/investing/2020/03/11/better-coronavirus-stock-gilead-sciences-vs-inovio.aspx
Better Coronavirus Stock: Gilead Sciences vs. Inovio Pharmaceuticals | The Motley Fool
Mar 11, 2020 - One biotech is developing a promising antiviral treatment for COVID-19. The other is developing a promising vaccine. But one stock is clearly the better pick.
gilead sciencesinovio pharmaceuticalsthe motleybettercoronavirus
https://www.finanznachrichten.de/nachrichten-2026-03/67936117-inovio-pharmaceuticals-inc-inovio-reports-fourth-quarter-and-full-year-2025-financial-results-and-recent-business-highlights-008.htm
INOVIO Pharmaceuticals, Inc.: INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results...
Biologics License Application (BLA) for INO-3107 accepted for review under the Accelerated Approval Program as a potential treatment for adults with Recurrent...
inovio pharmaceuticalsfourth quarter
https://www.macrotrends.net/stocks/charts/INO/inovio-pharmaceuticals/operating-income
Inovio Pharmaceuticals Operating Income 2012-2025 | INO | MacroTrends
Inovio Pharmaceuticals operating income from 2012 to 2025. Operating income can be defined as income after operating expenses have been deducted and before...
inovio pharmaceuticalsoperating income20122025macrotrends
https://www.biospace.com/inovio-pharmaceuticals-closes-87-4-million-underwritten-financing
Inovio Pharmaceuticals Closes $87.4 Million Underwritten Financing - BioSpace
inovio pharmaceuticals4 millioncloses87underwritten
https://www.fool.com/investing/2020/02/10/heres-why-inovio-pharmaceuticals-jumped-higher-tod.aspx
Here's Why Inovio Pharmaceuticals Jumped Higher Today | The Motley Fool
Feb 10, 2020 - The company is starting a new clinical trial, but that may not be the only thing boosting the biotech's shares.
here sinovio pharmaceuticalsthe motley
https://www.fool.com/investing/2020/08/13/whats-the-outlook-for-inovio-pharmaceutic/
What's the Outlook for Inovio Pharmaceuticals Stock? | The Motley Fool
Aug 13, 2020 - Its experimental coronavirus vaccine has some of the best clinical data among the 167 candidates in development.
what sthe outlookinovio pharmaceuticalsstockmotley
https://www.fool.com/investing/2020/03/10/citron-research-goes-after-inovio-pharmaceuticals.aspx
Citron Research Goes After Inovio Pharmaceuticals | The Motley Fool
Mar 10, 2020 - The activist short-seller is highly skeptical about the biotech's claims regarding its ongoing development of a coronavirus vaccine.
citron researchinovio pharmaceuticalsthe motleygoesfool
https://www.fool.com/investing/2016/08/15/better-buy-novavax-inc-vs-inovio-pharmaceuticals.aspx
Better Buy: Novavax, Inc. vs. Inovio Pharmaceuticals | The Motley Fool
Aug 15, 2016 - Is Novavax or Inovio Pharmaceuticals the better stock to take advantage of the high-growth vaccine industry?
better buynovavax incinovio pharmaceuticalsthe motleyvs
https://www.macrotrends.net/stocks/charts/INO/inovio-pharmaceuticals/price-sales
Inovio Pharmaceuticals Price to Sales Ratio 2012-2025 | INO | MacroTrends
Historical PS ratio values for Inovio Pharmaceuticals (INO) over the last 10 years. The current P/S ratio for Inovio Pharmaceuticals as of May 13, 2026 is...
price to sales ratioinovio pharmaceuticals20122025macrotrends
https://www.fool.com/investing/2018/04/30/is-inovio-pharmaceuticals-inc-ino-a-buy.aspx
Is Inovio Pharmaceuticals, Inc. (INO) a Buy? | The Motley Fool
Apr 30, 2018 - Weighing the arguments for and against the clinical-stage biotech.
inovio pharmaceuticalsthe motleyincbuyfool
https://www.fool.com/investing/2020/05/31/better-coronavirus-stock-moderna-or-inovio-pharmac.aspx
Better Coronavirus Stock: Moderna or Inovio Pharmaceuticals? | The Motley Fool
May 31, 2020 - The coronavirus vaccine race offers these clinical stage companies an opportunity to bring a first product to market -- if all goes well in human trials.
inovio pharmaceuticalsthe motleybettercoronavirusstock
https://www.fool.com/investing/general/2014/07/23/why-inovio-pharmaceuticals-inc-stock-livened-up-to.aspx
Why Inovio Pharmaceuticals Inc Stock Livened Up Today | The Motley Fool
Jul 23, 2014 - A phase 2 trial success lifts hope around Wall Street for Inovio's HPV-fighting vaccine VGX-3100
inovio pharmaceuticalsthe motleyincstock
https://www.macrotrends.net/stocks/charts/INO/inovio-pharmaceuticals/net-profit-margin
Inovio Pharmaceuticals Net Profit Margin 2012-2026 | INO | MacroTrends
Inovio Pharmaceuticals net profit margin from 2012 to 2026. Net profit margin can be defined as net Income as a portion of total sales revenue.
net profit margininovio pharmaceuticals20122026macrotrends
https://www.fool.com/earnings/call-transcripts/2022/11/08/inovio-pharmaceuticals-ino-q3-2022-earnings-call-t/
Inovio Pharmaceuticals (INO) Q3 2022 Earnings Call Transcript | The Motley Fool
Nov 9, 2022 - INO earnings call for the period ending September 30, 2022.
earnings call transcriptinovio pharmaceuticalsq3 2022the motley
https://finviz.com/quote?t=INO&ta=1&p=d&ty=oc
INO - Inovio Pharmaceuticals Inc Options
INO - Inovio Pharmaceuticals Inc - Stock screener for investors and traders, financial visualizations.
inovio pharmaceuticalsincoptions
https://www.fool.com/investing/2020/12/03/why-coronavirus-stock-inovio-pharmaceuticals-shot/
Why Coronavirus Stock Inovio Pharmaceuticals Shot Higher Today | The Motley Fool
Dec 3, 2020 - The company taps another partner to help make its coronavirus vaccine when, and if, it's approved.
inovio pharmaceuticalsthe motleycoronavirusstock
https://www.macrotrends.net/stocks/charts/INO/inovio-pharmaceuticals/total-liabilities
Inovio Pharmaceuticals Total Liabilities 2012-2025 | INO | MacroTrends
Inovio Pharmaceuticals total liabilities from 2012 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
inovio pharmaceuticalstotal liabilities20122025macrotrends
https://www.macrotrends.net/stocks/charts/INO/inovio-pharmaceuticals/operating-margin
Inovio Pharmaceuticals Operating Margin 2012-2026 | INO | MacroTrends
Current and historical operating margin for Inovio Pharmaceuticals (INO) over the last 10 years. The current operating profit margin for Inovio Pharmaceuticals...
inovio pharmaceuticalsoperating margin20122026macrotrends
https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-quotient-eldorado-resorts-carnival-corp-inovio-pharmaceuticals-or-american-eagle-outfitters-301048392.html
Thinking about buying stock in Quotient, Eldorado Resorts, Carnival Corp, Inovio Pharmaceuticals,...
/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for QTNT, ERI, CCL, INO, and AEO. To see how InvestorsObserver's proprietary scoring...
thinking about
https://www.benzinga.com/news/24/01/36713861/top-5-health-care-stocks-that-may-crash-this-month
Top 5 Health Care Stocks That May Crash This Month - Inovio Pharmaceuticals (NASDAQ:INO) - Benzinga
Jan 22, 2024 - As of Jan. 22, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading...
https://www.fool.com/investing/2018/08/08/why-inovio-pharmaceuticals-inc-stock-is-jumping-12.aspx
Why Inovio Pharmaceuticals, Inc. Stock Is Jumping 12.4% Today | The Motley Fool
Aug 8, 2018 - A Q2 update about the progress of a late-stage clinical study provides a nice boost to the clinical-stage biotech stock.
https://inovio.com/
INOVIO Pharmaceuticals
inoviopharmaceuticals
https://www.benzinga.com/analyst-ratings/analyst-color/22/07/28120874/rbc-capital-lowers-inovio-price-target-as-it-awaits-this
RBC Capital Lowers Inovio Price Target As It Awaits This - Inovio Pharmaceuticals (NASDAQ:INO) -...
https://www.prnewswire.com/news-releases/inovio-pharmaceuticals-inc-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights--ino-302734420.html
Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to...
/PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Inovio Pharmaceuticals, Inc. ("Inovio" or "the Company") (NASDAQ: INO)...
https://www.inovio.com/
INOVIO Pharmaceuticals
inoviopharmaceuticals